Breadcrumb

Breadcrumbs

PRODUCT_WITH_CATEGORY

Products

Daiichi Sankyo is primarily focused on developing novel therapies for people with cancer as well as other diseases with high unmet medical needs. Daiichi Sankyo, Inc. medicines approved in the U.S. are outlined below and include therapies for metastatic breast and gastric cancer, tenosynovial giant cell tumor, metastatic melanoma, hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, and IV iron therapy.

The Products listed below, which are currently FDA approved in the U.S., are the result.

Click to view Daiichi Sankyo Products available in other countries:

Worldwide

U.S. Products

Azor Product Logo

AZOR®

(amlodipine/olmesartan medoxomil)

See full prescribing information including boxed warning regarding fetal toxicity


Benicar Tablets Product Logo

BENICAR®

(olmesartan medoxomil)

See full prescribing information including boxed warning regarding fetal toxicity


Benicar HCT Product Logo

BENICAR HCT®

(olmesartan medoxomil/hydrochlorothiazide)

See full prescribing information including boxed warning regarding fetal toxicity


Effient Product Logo

EFFIENT®

(prasugrel) tablets

See full prescribing Information, including boxed warning regarding bleeding risk, and medication guide.


Injectafer Product Logo

INJECTAFER®

(ferric carboxymaltose injection)

See full prescribing Information


Tribenzor Product Logo

TRIBENZOR®

(olmesartan medoxomil/amlodipine/hydrochlorothiazide)

See full prescribing Information including boxed warning regarding fetal toxicity


Injectafer Product Logo

INJECTAFER®

(ferric carboxymaltose injection)

See full prescribing Information


Azor Product Logo

AZOR®

(amlodipine/olmesartan medoxomil)

See full prescribing information including boxed warning regarding fetal toxicity


Benicar Tablets Product Logo

BENICAR®

(olmesartan medoxomil)

See full prescribing information including boxed warning regarding fetal toxicity


Benicar HCT Product Logo

BENICAR HCT®

(olmesartan medoxomil/hydrochlorothiazide)

See full prescribing information including boxed warning regarding fetal toxicity


Effient Product Logo

EFFIENT®

(prasugrel) tablets

See full prescribing Information, including boxed warning regarding bleeding risk, and medication guide.


Tribenzor Product Logo

TRIBENZOR®

(olmesartan medoxomil/amlodipine/hydrochlorothiazide)

See full prescribing Information including boxed warning regarding fetal toxicity


Have a question about a product?

Please call the Daiichi Shankyo Contact Center at 1-877-4 DS-PROD
(1-877-437-7763) if you have a question about any of our products or to report
any adverse reactions to our products. To report negative side effects of
prescription drugs to the FDA, visit www.fda.gov/medwatch